Literature DB >> 19150884

Toll-like receptors 4 and 5 induce distinct types of vasculitis.

Jiusheng Deng1, Wei Ma-Krupa, Andrew T Gewirtz, Brian R Younge, Jörg J Goronzy, Cornelia M Weyand.   

Abstract

Large vessel vasculitides, such as Takayasu arteritis and giant cell arteritis, affect vital arteries and cause clinical complications by either luminal occlusion or vessel wall destruction. Inflammatory infiltrates, often with granulomatous arrangements, are distributed as a panarteritis throughout all of the artery's wall layers or cluster in the adventitia as a perivasculitis. Factors determining the architecture and compartmentalization of vasculitis are unknown. Human macrovessels are populated by indigenous dendritic cells (DCs) positioned in the adventitia. Herein, we report that these vascular DCs sense bacterial pathogens and regulate the patterning of the emerging arteritis. In human temporal artery-SCID chimeras, lipopolysaccharides stimulating Toll-like receptor (TLR)4 and flagellin stimulating TLR5 trigger vascular DCs and induce T-cell recruitment and activation. However, the architecture of the evolving inflammation is ligand-specific; TLR4 ligands cause transmural panarteritis and TLR5 ligands promote adventitial perivasculitis. Underlying mechanisms involve selective recruitment of functional T cell subsets. Specifically, TLR4-mediated DC stimulation markedly enhances production of the chemokine CCL20, biasing recruitment toward CCL20-responsive CCR6(+) T cells. In adoptive transfer experiments, CCR6(+) T cells produce an arteritis pattern with media-invasive T cells damaging vascular smooth muscle cells. Also, CCR6(+) T cells dominate the vasculitic infiltrates in patients with panarteritic giant cell arteritis. Thus, depending on the original danger signal, vascular DCs edit the emerging immune response by differentially recruiting specialized T effector cells and direct the disease process toward distinct types of vasculitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19150884      PMCID: PMC2731717          DOI: 10.1161/CIRCRESAHA.108.185777

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  27 in total

Review 1.  Giant cell arteritis and Takayasu aortitis: morphologic, pathogenetic and etiologic factors.

Authors:  M B Gravanis
Journal:  Int J Cardiol       Date:  2000-08-31       Impact factor: 4.164

2.  Essential role of CCR6 in directing activated T cells to the skin during contact hypersensitivity.

Authors:  Timothy J Paradis; Susan H Cole; Robin T Nelson; Ronald P Gladue
Journal:  J Invest Dermatol       Date:  2007-09-20       Impact factor: 8.551

3.  Therapeutic effects of acetylsalicylic acid in giant cell arteritis.

Authors:  Cornelia M Weyand; Markus Kaiser; Hongyu Yang; Brian Younge; Jörg J Goronzy
Journal:  Arthritis Rheum       Date:  2002-02

4.  Vasa vasoritis, vasculitis and atherosclerosis.

Authors:  F Numano
Journal:  Int J Cardiol       Date:  2000-08-31       Impact factor: 4.164

5.  TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS.

Authors:  Stefanie Zeuke; Artur J Ulmer; Shoichi Kusumoto; Hugo A Katus; Holger Heine
Journal:  Cardiovasc Res       Date:  2002-10       Impact factor: 10.787

6.  Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica?

Authors:  Denis Chatelain; Pierre Duhaut; Robert Loire; Sylvie Bosshard; Hélène Pellet; Jean-Charles Piette; Henri Sevestre; Jean-Pierre Ducroix
Journal:  Arthritis Rheum       Date:  2008-08

7.  Vessel wall-embedded dendritic cells induce T-cell autoreactivity and initiate vascular inflammation.

Authors:  Ji W Han; Kazunori Shimada; Wei Ma-Krupa; Tiffany L Johnson; Robert M Nerem; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circ Res       Date:  2008-01-17       Impact factor: 17.367

8.  Vessel-specific Toll-like receptor profiles in human medium and large arteries.

Authors:  Olga Pryshchep; Wei Ma-Krupa; Brian R Younge; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2008-09-02       Impact factor: 29.690

Review 9.  Taking dendritic cells into medicine.

Authors:  Ralph M Steinman; Jacques Banchereau
Journal:  Nature       Date:  2007-09-27       Impact factor: 49.962

10.  Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells.

Authors:  Hyung W Lim; Jeeho Lee; Peter Hillsamer; Chang H Kim
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

View more
  40 in total

Review 1.  Lower extremity vasculitis in polymyalgia rheumatica and giant cell arteritis.

Authors:  Tanaz A Kermani; Kenneth J Warrington
Journal:  Curr Opin Rheumatol       Date:  2011-01       Impact factor: 5.006

2.  Varicella zoster virus vasculopathy: analysis of virus-infected arteries.

Authors:  M A Nagel; I Traktinskiy; Y Azarkh; B Kleinschmidt-DeMasters; T Hedley-Whyte; A Russman; E M VanEgmond; K Stenmark; M Frid; R Mahalingam; M Wellish; A Choe; R Cordery-Cotter; R J Cohrs; D Gilden
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

3.  Vascular involvement in cardiac giant cell myocarditis: a new pathophysiological aspect.

Authors:  S Elezkurtaj; D Lassner; H-P Schultheiss; F Escher
Journal:  Clin Res Cardiol       Date:  2013-11-20       Impact factor: 5.460

Review 4.  Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Authors:  G A Ramirez; N Maugeri; M G Sabbadini; P Rovere-Querini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 5.  Takayasu arteritis--advances in diagnosis and management.

Authors:  Justin C Mason
Journal:  Nat Rev Rheumatol       Date:  2010-07       Impact factor: 20.543

6.  Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells.

Authors:  Yang Song; Hua Shen; Dominik Schenten; Peiying Shan; Patty J Lee; Daniel R Goldstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-10-27       Impact factor: 8.311

7.  Th17 and Th1 T-cell responses in giant cell arteritis.

Authors:  Jiusheng Deng; Brian R Younge; Richard A Olshen; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2010-02-08       Impact factor: 29.690

8.  Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis.

Authors:  Kisha Piggott; Jiusheng Deng; Kenneth Warrington; Brian Younge; Jessica T Kubo; Manisha Desai; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2011-01-10       Impact factor: 29.690

9.  Readressing the role of Toll-like receptor-4 alleles in inflammatory bowel disease: colitis, smoking, and seroreactivity.

Authors:  Anastassios C Manolakis; Andreas N Kapsoritakis; Anastasia Kapsoritaki; Elisavet K Tiaka; Konstantinos A Oikonomou; Vassilis Lotis; Dimitra Vamvakopoulou; Ioanna Davidi; Nikolaos Vamvakopoulos; Spyros P Potamianos
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

Review 10.  The immunopathology of giant cell arteritis: diagnostic and therapeutic implications.

Authors:  Cornelia M Weyand; Y Joyce Liao; Jörg J Goronzy
Journal:  J Neuroophthalmol       Date:  2012-09       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.